The authors' reply: Nonsustained hypercalcaemia and primary hyperparathyroidism in the PEARS cohort

Affiliations

Comment

Ning Yu et al. Clin Endocrinol (Oxf). 2013 Dec.

. 2013 Dec;79(6):899-900.

doi: 10.1111/cen.12308. Epub 2013 Sep 4.

¹ Dundee Epidemiology and Biostatistics Unit, Division of Population Health Sciences, University of Dundee, Dundee, Scotland.

No abstract available

Comment on

The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study.
Yu N, Leese GP, Smith D, Donnan PT. Yu N, et al. QJM. 2011 Jun;104(6):513-21. doi: 10.1093/qjmed/hcq261. Epub 2011 Jan 25. QJM. 2011. PMID: 21266486
What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS).
Yu N, Leese GP, Donnan PT. Yu N, et al. Clin Endocrinol (Oxf). 2013 Jul;79(1):27-34. doi: 10.1111/cen.12206. Epub 2013 Apr 19. Clin Endocrinol (Oxf). 2013. PMID: 23506565
Nonsustained hypercalcaemia and primary hyperparathyroidism in the PEARS cohort.
Bolland MJ, Grey A. Bolland MJ, et al. Clin Endocrinol (Oxf). 2013 Dec;79(6):899. doi: 10.1111/cen.12273. Epub 2013 Jul 15. Clin Endocrinol (Oxf). 2013. PMID: 23800075 No abstract available.